CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells

Science

Volumn 283, Issue 5399, 1999, Pages 225-229

  Schofield, Louis ^e   McConville, Malcolm J ^e   Hansen, Diana ^e   Campbell, A Stewart ^a   Fraser Reid, Bert ^b   Grusby, Michael J ^c,d   Tachado, Souvenir D ^e  

^a Insmed Incorporated   (United States)

^b Nat Prod Glycotechnology Res I   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN; GLYCOSYLPHOSPHATIDYLINOSITOL; IMMUNOGLOBULIN G;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ANTIGEN RECOGNITION; ARTICLE; HELPER CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NATURAL KILLER CELL; NONHUMAN; PLASMODIUM; PRIORITY JOURNAL; TRYPANOSOMA;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS; ANTIGENS, CD1; ANTIGENS, PROTOZOAN; ANTIGENS, SURFACE; CELLS, CULTURED; GLYCOSYLPHOSPHATIDYLINOSITOLS; IMMUNOGLOBULIN G; INTERLEUKIN-4; LECTINS, C-TYPE; LEISHMANIA MEXICANA; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED STRAINS; PLASMODIUM; PROTEINS; PROTOZOAN PROTEINS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; TRYPANOSOMA BRUCEI BRUCEI; VARIANT SURFACE GLYCOPROTEINS, TRYPANOSOMA;

ANIMALIA; TRYPANOSOMA;

EID: 0033534391     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.283.5399.225     Document Type: Article

References (47)

1. H. Arase, N. Arase, K. Ogasawara, R. A. Good, K. Onoe, Proc. Natl. Acad. Sci. U.S.A. 89, 6506 (1992); A. Bendelac, N. Killeen, D. R. Littman, R. H. Schwartz, Science 263, 1774 (1994); A. Bendelac, J. Exp. Med. 182, 2091 (1995).
2. H. Arase, N. Arase, K. Ogasawara, R. A. Good, K. Onoe, Proc. Natl. Acad. Sci. U.S.A. 89, 6506 (1992); A. Bendelac, N. Killeen, D. R. Littman, R. H. Schwartz, Science 263, 1774 (1994); A. Bendelac, J. Exp. Med. 182, 2091 (1995).
3. H. Arase, N. Arase, K. Ogasawara, R. A. Good, K. Onoe, Proc. Natl. Acad. Sci. U.S.A. 89, 6506 (1992); A. Bendelac, N. Killeen, D. R. Littman, R. H. Schwartz, Science 263, 1774 (1994); A. Bendelac, J. Exp. Med. 182, 2091 (1995).
4. T. Yoshimoto and W. E. Paul, J. Exp. Med. 179, 1285 (1994); T. Yoshimoto, A. Bendelac, C. Watson, J. Hu-Li, W. E. Paul, Science 270, 1845 (1995); T. Yoshimoto, A. Bendelac, J. Hu-Li, W. E. Paul, Proc. Natl. Acad. Sci. U.S.A. 92, 11931 (1995).
5. T. Yoshimoto and W. E. Paul, J. Exp. Med. 179, 1285 (1994); T. Yoshimoto, A. Bendelac, C. Watson, J. Hu-Li, W. E. Paul, Science 270, 1845 (1995); T. Yoshimoto, A. Bendelac, J. Hu-Li, W. E. Paul, Proc. Natl. Acad. Sci. U.S.A. 92, 11931 (1995).
6. T. Yoshimoto and W. E. Paul, J. Exp. Med. 179, 1285 (1994); T. Yoshimoto, A. Bendelac, C. Watson, J. Hu-Li, W. E. Paul, Science 270, 1845 (1995); T. Yoshimoto, A. Bendelac, J. Hu-Li, W. E. Paul, Proc. Natl. Acad. Sci. U.S.A. 92, 11931 (1995).
7. M. Bix, M. Coles, D. Raulet, J. Exp. Med. 178, 901 (1993); O. Lantz and A. Bendelac, J. ibid. 180, 1097 (1994); Y. Makino, R. Kanno, T. Ito, K. Higashino, M. Taniguchi, M. Immunol. 7, 1157 (1995).
8. M. Bix, M. Coles, D. Raulet, J. Exp. Med. 178, 901 (1993); O. Lantz and A. Bendelac, J. ibid. 180, 1097 (1994); Y. Makino, R. Kanno, T. Ito, K. Higashino, M. Taniguchi, M. Immunol. 7, 1157 (1995).
9. M. Bix, M. Coles, D. Raulet, J. Exp. Med. 178, 901 (1993); O. Lantz and A. Bendelac, J. ibid. 180, 1097 (1994); Y. Makino, R. Kanno, T. Ito, K. Higashino, M. Taniguchi, M. Immunol. 7, 1157 (1995).
10. S. Porcelli, C. T. Morita, M. B. Brenner, Nature 360, 593 (1992); E. M. Beckman et al., ibid. 372, 691 (1994); P. A. Sieling et al., Science 269, 227 (1995).
11. S. Porcelli, C. T. Morita, M. B. Brenner, Nature 360, 593 (1992); E. M. Beckman et al., ibid. 372, 691 (1994); P. A. Sieling et al., Science 269, 227 (1995).
12. S. Porcelli, C. T. Morita, M. B. Brenner, Nature 360, 593 (1992); E. M. Beckman et al., ibid. 372, 691 (1994); P. A. Sieling et al., Science 269, 227 (1995).
13. T. Kawano et al., Science 278, 1626 (1997); L. Brossay et al., J. Immunol. 161, 5124 (1998).
14. T. Kawano et al., Science 278, 1626 (1997); L. Brossay et al., J. Immunol. 161, 5124 (1998).
15. S. Joyce et al., ibid. 279, 1541 (1998).
16. z reciprocal IgG titers of 15.14, 13.5, and 13.5, respectively. The equivalent values for allogeneic chimeras were 4.5, 4.25, and 13. For syngeneic bone-marrow chimeras the equivalent values were 15.11, 11.25, and 14.6, and for allogeneic chimeras 8.5, 7.25, and 15.25, respectively.
17. W. R. Weiss, M. Sedegah, J. A. Berzofsky, S. L. Hoffman, J. Immunol. 151, 2690 (1993).
18. D. Cosgrove et al., Cell 66, 1051 (1991); M. J. Grusby, R. S. Johnson, V. E. Papaioannou, L. H. Glimcher, Science 253, 1417 (1991); F. Köntgen, G. Süss, C. Stewart, M. Steinmetz, H. Bluethmann, Int. Immunol. 5, 957 (1993).
19. D. Cosgrove et al., Cell 66, 1051 (1991); M. J. Grusby, R. S. Johnson, V. E. Papaioannou, L. H. Glimcher, Science 253, 1417 (1991); F. Köntgen, G. Süss, C. Stewart, M. Steinmetz, H. Bluethmann, Int. Immunol. 5, 957 (1993).
20. D. Cosgrove et al., Cell 66, 1051 (1991); M. J. Grusby, R. S. Johnson, V. E. Papaioannou, L. H. Glimcher, Science 253, 1417 (1991); F. Köntgen, G. Süss, C. Stewart, M. Steinmetz, H. Bluethmann, Int. Immunol. 5, 957 (1993).
21. 2 reciprocal titer of 10, 8, 8.25, and 9.75, respectively). Immunoglobulin isotypes included IgG1, IgG2a, and IgG2b.
22. P. Moran and I. W. Caras, J. Cell Biol. 125, 333 (1994).
23. 1H NMR compositional analyses demonstrating purity of the synthetic Thy-1 GPI and IPG (14).
24. M. J. McConville and J. M. Blackwell, J. Biol. Chem. 266, 15170 (1991); M. J. McConville, T. A. C. Collidge, M. A. J. Ferguson, P. Schneider, ibid. 268, 15595 (1993); J. E. Ralton and M. J. McConville, ibid. 273, 4245 (1998).
25. M. J. McConville and J. M. Blackwell, J. Biol. Chem. 266, 15170 (1991); M. J. McConville, T. A. C. Collidge, M. A. J. Ferguson, P. Schneider, ibid. 268, 15595 (1993); J. E. Ralton and M. J. McConville, ibid. 273, 4245 (1998).
26. M. J. McConville and J. M. Blackwell, J. Biol. Chem. 266, 15170 (1991); M. J. McConville, T. A. C. Collidge, M. A. J. Ferguson, P. Schneider, ibid. 268, 15595 (1993); J. E. Ralton and M. J. McConville, ibid. 273, 4245 (1998).
27. A. S. Campbell and B. Fraser-Reid, J. Am. Chem. Soc. 117, 10387 (1995).
28. A. Bendelac et al., Science 268, 863 (1995); S. Cardell et al., J. Exp. Med. 182, 993 (1995).
29. A. Bendelac et al., Science 268, 863 (1995); S. Cardell et al., J. Exp. Med. 182, 993 (1995).
30. / donors were bulk cultured in flat-bottomed plates in the presence or absence of PfGPI and iM4 for 4 days. The proportion of NKT cells expressing intracellular IL-4 was measured by flow cytometry after subtraction of background staining by isotype-matched fluorescein isothiocyanate-conjugated control monoclonal antibody R35-38.
31. D. B. Moody, et al., Science 278, 283 (1997).
32. H. Chen and W. E. Paul, J. Immunol. 159, 2240 (1997); H. Chen, H. Huang, W. E. Paul, ibid. 158, 5112 (1997).
33. H. Chen and W. E. Paul, J. Immunol. 159, 2240 (1997); H. Chen, H. Huang, W. E. Paul, ibid. 158, 5112 (1997).
34. S. T. Smiley, M. H. Kaplan, M. J. Grusby, Science 275, 977 (1997).
35. L. Brossay et al., J. Immunol. 159, 1216 (1997); L. Brossay et al., ibid. 160, 3681 (1998).
36. L. Brossay et al., J. Immunol. 159, 1216 (1997); L. Brossay et al., ibid. 160, 3681 (1998).
37. S. H. Park, J. H. Roark, A. Bendelac, ibid., p. 3128.
38. S. A. Porcelli, Adv. Immunol. 59, 1 (1995); A. Bendelac, M. N. Rivera, S.-H. Park, J. H. Roark, Annu. Rev. Immunol. 15, 535 (1997).
39. S. A. Porcelli, Adv. Immunol. 59, 1 (1995); A. Bendelac, M. N. Rivera, S.-H. Park, J. H. Roark, Annu. Rev. Immunol. 15, 535 (1997).
40. P. Matzinger, Annu. Rev. Immunol. 12, 991 (1994).
41. M. F. Good, S. Kumar, L. H. Miller, Immunol. Today 9, 351 (1988).
42. b (28-8-6), H-2 (M1/42), and IL-4 (11B11, BVD6-24G2, BVD4-1D11).
43. P. J. Romero et al., Eur. J. Immunol. 18, 1951 (1988).
44. M. W. Clarke, R. W. Olafson, T. W. Pearson, Mol. Biochem. Parasitol. 17, 19 (1985); L. Schofield and F. Hackett, J. Exp. Med. 177, 145 (1993); S. D. Tachado et al., Proc. Natl. Acad. Sci. U.S.A. 94, 4022 (1997).
45. M. W. Clarke, R. W. Olafson, T. W. Pearson, Mol. Biochem. Parasitol. 17, 19 (1985); L. Schofield and F. Hackett, J. Exp. Med. 177, 145 (1993); S. D. Tachado et al., Proc. Natl. Acad. Sci. U.S.A. 94, 4022 (1997).
46. M. W. Clarke, R. W. Olafson, T. W. Pearson, Mol. Biochem. Parasitol. 17, 19 (1985); L. Schofield and F. Hackett, J. Exp. Med. 177, 145 (1993); S. D. Tachado et al., Proc. Natl. Acad. Sci. U.S.A. 94, 4022 (1997).
47. We thank M. Kronenberg for the CD1-transfectants and monoclonal antibody 1B1 and M. Taniguchi for CMS-1. Supported by the United Nations Development Program/World Bank/World Health Organization Special Program for Research and Training in Tropical Diseases, the Australian Academy of Science (L.S.), NIH grant GM 41071 (B.F.-R. and S.C.), INSMED (B.F.-R.), NIH grant AI-40171, and a gift from the Mathers Foundation (M.J.G.). M.J.M. is a Wellcome Trust Senior Research Fellow. M.J.G. is a Scholar of the Leukemia Society of America.